Cybin's latest patent application is in support of its proprietary digital therapeutics platform for mental health treatment.
Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD
Numinus receives Health Canada approval to move forward with MAPS in its clinical testing for PTSD.
Are Joe Biden And Congress Patriotic Enough To Legalize Psychedelic Medicine?
"Support the troops" the White House and Congress tell Americans, over and over. When will THEY start to support the troops? Psychedelic medicine would be a great place to start.
Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio
Cybin seeks to build an international footprint via scaling up activities in Europe with its Ireland subsidiary, including the transfer of its IP assets.
Novamind Selected as Research Site for Bionomics' PTSD Clinical Trial
Novamind's clinics have been selected as a research site by atai-partner, Bionomics Limited for a Phase IIb clinical trial.
MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company
MindMed's new partnership with Datavant will enhance its data-collection/data-reporting as MindMed moves through its clinical trials.
Let’s Defund The DEA
The U.S. Drug Enforcement Agency is a bureaucratic relic that regularly demonstrates it has no place in a world of 21st century drug reform.
The 6 Leading Psychedelic Stocks in Drug R&D
The emerging psychedelic drug sector represents the most lucrative opportunities in life sciences today. We compare and contrast six of the drug R&D leaders.
Psychedelic Stocks: An Investing Hedge For A Crazy World
As investors become increasingly concerned about hedging their portfolios, there are few safe alternatives. Psychedelic stocks are a sane choice for a crazy world.
Maxim Group Initiates Coverage of Mind Cure Health
Analysts Jason McCarthy and Michael Okunewitch of Maxim Group have initiated coverage of Mind Cure Health.
The Mental Health Pandemic Soars Into Focus, Psychedelics In The Spotlight
As the Mental Health Pandemic spirals out of control, we see a positive sign: the mainstream media has finally noticed it.
MindMed Included in FTSE Russell 3000® Index
MindMed officially announces its inclusion in the FTSE Russell 3000.
